Investigation of platelet aggregation inhibitory activity by phenyl amides and esters of piperidinecarboxylic acids
Authors:
- Modesto de CandiaModesto de Candia
- Luciana SummoLSLuciana Summo
- Antonio CarrieriAntonio Carrieri
- Cosimo AltomareCACosimo Altomare
- Adele NardecchiaANAdele Nardecchia
- Saverio CellamareSCSaverio Cellamare
- Angelo CarottiACAngelo Carotti
- 1 April 2003
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 11 (7) , 1439-1450
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Current Oral Antiplatelet Agents to Prevent AtherothrombosisCerebrovascular Diseases, 2001
- Antiplatelet therapy in the elderly: Aspirin, ticlopidine–clopidogrel, and GPIIb/GPIIIa antagonistsClinics in Geriatric Medicine, 2001
- ADP Receptors of Platelets and their InhibitionThrombosis and Haemostasis, 2001
- Antiplatelet medications and their indications in preventing and treating coronary thrombosisAnnals of Medicine, 2000
- The thienopyridines in coronary artery disease.Current Cardiology Reports, 1999
- Multiple P2 receptor subtypes on platelets: a new interpretation of their functionTrends in Pharmacological Sciences, 1998
- Antiplatelet DrugsDrugs, 1995
- Molecular determinants of the platelet aggregation inhibitory activity of carbamoylpiperidinesJournal of Medicinal Chemistry, 1992
- Thrombotic and Bleeding Complications of Prosthetic Heart ValvesThe Annals of Thoracic Surgery, 1987
- Deep arterial injury during experimental angioplasty: Relation to a positive indium-111-labeled platelet scintigram, quantitative platelet deposition and mural thrombosisJACC, 1986